MedTech News
FDA accepts BiVacor Total Artificial Heart into TAP advisory program
BiVacor announced today that the FDA accepted its Total Artificial Heart (TAH) into its Total Product LifeCycle Advisory Program (TAP).
Meet the hemifusome – a new structure discovered inside human cells -a previously unknown structure hiding inside human cells.
This mysterious organelle may play a vital role in how our cells recycle and process material, with major implications for disease research
Human instruction with AI guidance provides best results in neurosurgical training, study finds
Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.
Virtual reality shows promise in easing stress for cardiac patients
Living with cardiovascular disease often takes a serious emotional toll—and with stress known to worsen heart health, there’s growing interest in low-risk, innovative ways to help patients cope. New research from UCLA Health suggests that virtual reality (VR) may offer a promising tool to ease psychological stress and support heart health.
Researchers grow human kidney organoids from stem cells, mirroring fetal kidney development over months
For the first time, researchers from both Sheba Medical Center and Tel Aviv University have grown human kidney organoids (a synthetic 3D organ culture) from tissue stem cells in the laboratory, mirroring human fetal kidney development.
Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis
Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called “O2E” that allows clinics to detect cancerous lesions in the esophagus with unprecedented precision.
3D-printed cardiac patch encourages tissue repair using structural mesh and hydrogel with living cells
A new type of tissue-engineered cardiac patch could not only seal defective areas of the heart, as has been the case up to now, but also heal them. An interdisciplinary team led by ETH Zurich has successfully implanted the patch in animals.
AbbVie receives marketing authorization from MHRA
AbbVie has announced that it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult patients with folate receptor-alpha (FRα) positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens.